Pharmacogenomics

At geneOmbio, we pioneer precision medicine through advanced pharmacogenomics (PGx) testing, helping doctors prescribe the right medication at the right dose based on your unique genetic profile.

bt_bb_section_bottom_section_coverage_image

Why Pharmacogenomics Matters?

Did you know?

50% of patients don’t respond to their first prescribed antidepressant 30% of adverse drug reactions could be prevented with genetic testing Warfarin dosing can be 10x more accurate with genetic guidance

Our Sanger sequencing and TaqMan genotyping-based tests analyze how your genes affect:

Drug metabolism (fast vs. slow processors) Medication effectiveness Risk of serious side effects

What is Pharmacogenomics?

Pharmacogenomics is a cutting-edge field that combines pharmacology (the science of drugs) and genomics (the study of genes) to understand how genes influence an individual’s response to medications.

This innovative approach allows for more personalized medicine, moving away from the “one-dose-fits-all” model.

By analyzing your DNA, pharmacogenomics testing can predict how your body will process and respond to specific drugs, leading to:

Safer medication choices
More effective treatment outcomes
Reduced risk of adverse drug reactions
Personalized dosage recommendations

geneOmbio's Pharmacogenomics Services

geneOmbio provides comprehensive pharmacogenomic testing to support various medical specialties

Fertility Support:Personalized medication strategies for fertility treatments.
Psychiatry Support: Guidance on selecting and dosing psychiatric medications.
Onco Support:Pharmacogenomics testing to inform cancer treatment decisions.
Dermatology Support: Genetic insights for dermatological drug therapies.
Cardiac Support:Personalized medication management for cardiac patients.
Pharmacogenomics for CROs:Genotyping services for clinical trials and research.

With geneOmbio’s pharmacogenomics testing, healthcare providers can make more informed decisions, leading to better patient care and improved treatment success.

Our Publication

✔ Improved probes for detection of V617F mutation in chromosome 9-borne JAK2 gene linked to conditions of Polycythemia Vera and other myeloproliferative disorders. Archives of Medicine (2009)

✔ Optimizing protocol for re-sequencing of kinase domain within EFGR gene to identify mutations associated with resistance to small molecule TKI in non-small cell lung cancer patients. The Third International Conference on Research and New Perspective in Developing Science (2012)

✔ Peptide Based Viral Detection Systems For Effective Diagnosis of Common Viral Infections In India. Current Protein and Peptide Science (2016)

✔ Rapid detection of the HLA-B*5701 allele by in-house developed tetra-primer amplification refractory mutation system PCR. Meta Gene (2017)

✔ Improved probes for detection of V617F mutation in chromosome 9-borne JAK2 gene linked to conditions of Polycythemia Vera and other myeloproliferative disorders. Archives of Medicine (2009)

✔ Peptide Based Viral Detection Systems For Effective Diagnosis of Common Viral Infections In India. Current Protein and Peptide Science (2016)

✔ Rapid detection of the HLA-B*5701 allele by in-house developed tetra-primer amplification refractory mutation system PCR. Meta Gene (2017)

Key Benefits of Fertility Support

Our Fertility Support panel offers valuable information in two crucial areas:

Personalized Drug Dosage:This panel analyzes genes that influence the metabolism and effectiveness of fertility drugs, including FSH (follicle-stimulating hormone) and Gonadotropins. By understanding your genetic variations, your doctor can determine the optimal drug dosage, minimizing side effects and maximizing treatment efficacy.
Ovarian Response Prediction:The test provides a comprehensive genetic analysis of important markers that play a role in ovarian response to IVF treatment. This information helps predict how your ovaries will respond to stimulation, allowing for more personalized treatment planning and better management of expectations.

Improve Your Chances of IVF Success with Genetic Insights

GeneOmbio’s Fertility Support empowers fertility specialists to move beyond a “one-size-fits-all” approach and provide truly personalized care. By incorporating genetic information into the treatment plan, we aim to:

Increase the likelihood of successful IVF outcomes
Reduce the time and cost associated with multiple IVF cycles
Minimize the risk of complications and side effects

If you are considering IVF, geneOmbio’s Fertility Support can provide valuable insights to optimize your treatment and enhance your journey to parenthood.

Our Services

Compréhensive Pharmacogenomics Solutions

Nutrigenomics Panels

Fertility Support is India’s first comprehensive genetic screen for reproductive...

Psychiatry Support

Pharmacogenomic testing in psychiatry plays a major role in deciding the treatment...

Onco Support

geneOmbio’s Onco Support panels include cancer diagnosis and treatment guide based...

Dermatology Support

As genomics technologies continue to bring in new avenues and platforms in research and...

Cardiac Support

geneOmbio provides gene based personalized medicine for cardiac patients with...

Pharmacogenomics for CROs

geneOmbio has been providing genotyping services for various clinical trials and...

Fertility & IVF Support

Optimize IVF success rates with genetic insights into:

FSH & Gonadotropins response (TaqMan genotyping) Ovarian reserve & egg quality (Sanger sequencing) Folate metabolism (MTHFR) for embryo health

Mental Health & Psychiatry

Eliminate trial-and-error prescribing for:

Antidepressants (SSRIs, SNRIs) CYP2D6/CYP2C19 Antipsychotics HLA-B*15:02 risk screening ADHD medications personalized dosing

Cancer & Oncology Support

Enhance treatment safety & efficacy:

TPMT testing before thiopurine chemo (Sanger) EGFR mutations for lung cancer therapy Imatinib resistancein CML/GIST

Heart & Cardiovascular Care

Prevent dangerous complications with:

Warfarin sensitivity (CYP2C9/VKORC1) Clopidogrel resistance(CYP2C19) Statin intolerance risk (SLCO1B1)

Dermatology & Autoimmune

Personalize treatment for:

Hair loss (Finasteride response) Psoriasis/eczema (Methotrexate sensitivity) Autoimmune therapies (Azathioprine safety)